Long non-coding RNAs and their potential role in predicting immunotherapy response and prognosis: a systematic review - Top-Institutions - MDSpire

Long non-coding RNAs and their potential role in predicting immunotherapy response and prognosis: a systematic review

  • By

  • Lamia K. Alshamlani

  • Sara M. Alrowaydan

  • Nora S. Almutairi

  • Manar A. Alomar

  • Faizah M. Alotaibi

  • July 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    GARNET trial
    GARNET trial

    N/A, N/A

    Key Differentiators

    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology

  • #4

    Gustave Roussy
    Gustave Roussy

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology

  • #5

    The Cancer Genome Atlas
    The Cancer Genome Atlas

    N/A, N/A

    Key Differentiators

    • Oncology

Original Source(s)

Long non-coding RNAs and their potential role in predicting immunotherapy response and prognosis: a systematic review

  • by Lamia K. Alshamlani, Sara M. Alrowaydan, Nora S. Almutairi, Manar A. Alomar, Faizah M. Alotaibi

  • July 10, 2026

Related Content

Beyond AUC: a clinician’s guide to building and trusting prediction models in oncology—a narrative review

A systematic review on colon cancer classification by convolutional neural networks: Architecture, accuracy, and research directions

KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis